Bogdan Tsubera
Bogdan Tsubera has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Skums
Shalimov National Scientific Center of Surgery and Transplantation
3 shared publications - O. M. Gulko
Національний інститут хірургії та трансплантології імені О. О. Шалімова НАМН України, м. Київ
3 shared publications - O. M. Simonov
Державна установа «Національний науковий центр хірургії та трансплантології імені О. О. Шалімова» Національної академії медичних наук України, Київ, Україна
3 shared publications - P. V. Hurin
National Scientific Center for Surgery and Transplantology named after O.O. Shalimov of NAMSU, Kyiv, Ukraine
3 shared publications - I. P. Halochka
Shupyk National University of Health of Ukraine
2 shared publications - I. S. Tereshkevich
Shalimov National Institute of Surgery and Transplantology, Kyiv
2 shared publications
Latest Publications
- Open Access
- 23 February 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (1) , 69-73
Genotype-phenotype correlations and clinical significance of genetic testing in pheochromocytomas and paragangliomas
Objective. To evaluate the role of molecular genetic testing in patients with pheochromocytomas and paragangliomas, to determine genotype-phenotype correlations and their impact on clinical characteristics, imaging approaches, and prognosis. Materials and methods. The prospective study included 14 patients hospitalized at the O. O. Shalimov National Scientific Center for Surgery and Transplantology of the National Academy of Medical Sciences of Ukraine in 2018–2025. All patients underwent genetic testing using next-generation sequencing with confirmation of mutations by the Sanger method, biochemical examination (liquid chromatography–tandem mass spectrometry for metanephrines, normetanephrines, 3-methoxytyramine), morphological and immunohistochemical studies. Computed tomography and magnetic resonance imaging were performed, as well as functional imaging (positron emission tomography/computed tomography using the radiopharmaceuticals DOTA-SSA and FDOPA). Descriptive and comparative statistics were used for statistical analysis. Results. Pathogenic or likely pathogenic gene mutations were detected in 12 (85.7%) of 14 patients. The most common were SDHB gene mutations (64.3%), associated with a noradrenergic or "biochemically silent" phenotype and a high risk of metastasis (21.4%). Patients with VHL and RET (MEN2A) gene mutations had characteristic multifocality and bilateral tumors. Functional imaging revealed genotype-specific patterns: positron emission tomography/computed tomography with DOTA-SSA demonstrated high sensitivity in SDHB-associated tumors (over 90%), while FDOPA was optimal for VHL- and RET/NF1-associated tumors. The disease debuted earliest in patients with SDHB-associated tumors (median age 32 years), and its clinical manifestations differed depending on the genotype. Conclusions. Molecular genetic testing is critically important for risk stratification and personalized management of patients with pheochromocytomas/paragangliomas. Identification of genotype-phenotype correlations enables disease prognosis, informed choice of functional imaging method, planning of screening for first-degree relatives , and determination of therapeutic strategy, including theranostic approaches.
- 23 February 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (1) , 69-73
Open AccessGenotype-phenotype correlations and clinical significance of genetic testing in pheochromocytomas and paragangliomas
Objective. To evaluate the role of molecular genetic testing in patients with pheochromocytomas and paragangliomas, to determine genotype-phenotype correlations and their impact on clinical characteristics, imaging approaches, and prognosis. Materials and methods. The prospective study included 14 patients hospitalized at the O. O. Shalimov National Scientific Center for Surgery and Transplantology of the National Academy of Medical Sciences of Ukraine in 2018–2025. All patients underwent genetic testing using next-generation sequencing with confirmation of mutations by the Sanger method, biochemical examination (liquid chromatography–tandem mass spectrometry for metanephrines, normetanephrines, 3-methoxytyramine), morphological and immunohistochemical studies. Computed tomography and magnetic resonance imaging were performed, as well as functional imaging (positron emission tomography/computed tomography using the radiopharmaceuticals DOTA-SSA and FDOPA). Descriptive and comparative statistics were used for statistical analysis. Results. Pathogenic or likely pathogenic gene mutations were detected in 12 (85.7%) of 14 patients. The most common were SDHB gene mutations (64.3%), associated with a noradrenergic or "biochemically silent" phenotype and a high risk of metastasis (21.4%). Patients with VHL and RET (MEN2A) gene mutations had characteristic multifocality and bilateral tumors. Functional imaging revealed genotype-specific patterns: positron emission tomography/computed tomography with DOTA-SSA demonstrated high sensitivity in SDHB-associated tumors (over 90%), while FDOPA was optimal for VHL- and RET/NF1-associated tumors. The disease debuted earliest in patients with SDHB-associated tumors (median age 32 years), and its clinical manifestations differed depending on the genotype. Conclusions. Molecular genetic testing is critically important for risk stratification and personalized management of patients with pheochromocytomas/paragangliomas. Identification of genotype-phenotype correlations enables disease prognosis, informed choice of functional imaging method, planning of screening for first-degree relatives , and determination of therapeutic strategy, including theranostic approaches.
- Open Access
- 24 October 2025
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 92 (5) , 50-59
Comprehensive personalized approach to the diagnosis and treatment of pheochromocytoma and paraganglioma
Objective. To evaluate the effectiveness of a comprehensive approach to the diagnosis and treatment of pheochromocytoma and paraganglioma with a special focus on the role of selective venous blood sampling, X–ray endovascular selective electrocoagulation occlusion, and biochemical stratification in optimizing surgical tactics in domestic clinical practice. Materials and methods. The study included 248 patients with morphologically confirmed pheochromocytomas and paragangliomas who were treated at the O. O. Shalimov National Scientific Center for Surgery and Transplantology in 2016–2025: 129 (52.0%) women and 119 (48.0%) men, with an average age of 47.0 (± 10.0) years. Shalimov National Scientific Center for Surgery and Transplantology in 2016–2025: 129 (52.0%) women and 119 (48.0%) men, with a mean age of (43.8 ± 12.4) years. All patients underwent blood plasma metanephrine level determination using high–performance liquid chromatography with tandem mass spectrometry, as well as computed tomography and magnetic resonance imaging. Selective venous blood sampling was performed in 35 patients with complex diagnoses, and selective endovascular electrocoagulation occlusion was performed in 183 patients as part of preoperative preparation. Next–generation sequencing genetic testing was performed in 12 patients. All patients underwent surgery after adequate α–blockade. Results. Elevated metanephrine levels were detected in 91.9% of patients. In 75% of patients with "biochemically silent" tumors, the diagnosis was established by determining the level of 3–methoxytyramine. Selective venous blood sampling allowed lateralization in 80% of patients and changed surgical tactics in 31.4% of patients, avoiding bilateral adrenalectomy in 5 patients. X–ray endovascular selective electrocoagulation occlusion led to normalization of metanephrine levels in 66.7% and ensured hemodynamic stability during surgery in 91.8% of patients. The average blood loss after this procedure was (66.4 ± 12.2) ml. Mutations in genes were detected in 83.3% of patients, mainly in the SDHB gene (90%). The overall incidence of postoperative complications was 8.9%, and the three–year recurrence–free survival rate was 92.1%. Conclusions. A comprehensive approach using selective venous blood sampling and X–ray endovascular selective electrocoagulation occlusion significantly improves the results of treatment for pheochromocytoma and paraganglioma. Selective venous blood sampling allows optimizing surgical tactics and avoiding unnecessary bilateral adrenalectomies. X–ray endovascular selective electrocoagulation occlusion effectively reduces hormonal load and intraoperative risks. Determination of 3–methoxytyramine levels increases diagnostic sensitivity in patients with "biochemically silent" tumors. Genetic testing is critical for predicting the course of the disease.
- 24 October 2025
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 92 (5) , 50-59
Open AccessComprehensive personalized approach to the diagnosis and treatment of pheochromocytoma and paraganglioma
Objective. To evaluate the effectiveness of a comprehensive approach to the diagnosis and treatment of pheochromocytoma and paraganglioma with a special focus on the role of selective venous blood sampling, X–ray endovascular selective electrocoagulation occlusion, and biochemical stratification in optimizing surgical tactics in domestic clinical practice. Materials and methods. The study included 248 patients with morphologically confirmed pheochromocytomas and paragangliomas who were treated at the O. O. Shalimov National Scientific Center for Surgery and Transplantology in 2016–2025: 129 (52.0%) women and 119 (48.0%) men, with an average age of 47.0 (± 10.0) years. Shalimov National Scientific Center for Surgery and Transplantology in 2016–2025: 129 (52.0%) women and 119 (48.0%) men, with a mean age of (43.8 ± 12.4) years. All patients underwent blood plasma metanephrine level determination using high–performance liquid chromatography with tandem mass spectrometry, as well as computed tomography and magnetic resonance imaging. Selective venous blood sampling was performed in 35 patients with complex diagnoses, and selective endovascular electrocoagulation occlusion was performed in 183 patients as part of preoperative preparation. Next–generation sequencing genetic testing was performed in 12 patients. All patients underwent surgery after adequate α–blockade. Results. Elevated metanephrine levels were detected in 91.9% of patients. In 75% of patients with "biochemically silent" tumors, the diagnosis was established by determining the level of 3–methoxytyramine. Selective venous blood sampling allowed lateralization in 80% of patients and changed surgical tactics in 31.4% of patients, avoiding bilateral adrenalectomy in 5 patients. X–ray endovascular selective electrocoagulation occlusion led to normalization of metanephrine levels in 66.7% and ensured hemodynamic stability during surgery in 91.8% of patients. The average blood loss after this procedure was (66.4 ± 12.2) ml. Mutations in genes were detected in 83.3% of patients, mainly in the SDHB gene (90%). The overall incidence of postoperative complications was 8.9%, and the three–year recurrence–free survival rate was 92.1%. Conclusions. A comprehensive approach using selective venous blood sampling and X–ray endovascular selective electrocoagulation occlusion significantly improves the results of treatment for pheochromocytoma and paraganglioma. Selective venous blood sampling allows optimizing surgical tactics and avoiding unnecessary bilateral adrenalectomies. X–ray endovascular selective electrocoagulation occlusion effectively reduces hormonal load and intraoperative risks. Determination of 3–methoxytyramine levels increases diagnostic sensitivity in patients with "biochemically silent" tumors. Genetic testing is critical for predicting the course of the disease.
- Open Access
- 24 December 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 91 (6) , 13-17
Endoscopic argon plasma coagulation as a method of haemostasis in bleeding from pancreatogastroanastomosis after pancreaticoduodenectomy
Objective. To evaluate the results of endoscopic argon plasma coagulation to stop bleeding from the pancreatogastroanastomosis after pancreaticoduodenectomy. Materials and methods. During the period 2019–2023, 48 pancreaticoduodenectomies were performed. At the stage of reconstruction, pancreatogastrostomy was used for the first time as an alternative to pancreatic jejunostomy. This type of reconstruction has a number of technical and anatomical advantages. Results. The incidence of postoperative bleeding was 12.5% (n=6). In all observations, intraluminal bleeding from the pancreatic stump into the gastric lumen was noted, which was not associated with the development of a pancreatic fistula. The use of argon plasma coagulation provided a one–stage bleeding control without the need for relaparotomy. Conclusions. Our clinical experience has shown encouraging immediate results. Argon plasma coagulation can be successfully used for bleeding from the pancreatic stump into the gastric lumen without the risk of anastomotic failure.
- 24 December 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 91 (6) , 13-17
Open AccessEndoscopic argon plasma coagulation as a method of haemostasis in bleeding from pancreatogastroanastomosis after pancreaticoduodenectomy
Objective. To evaluate the results of endoscopic argon plasma coagulation to stop bleeding from the pancreatogastroanastomosis after pancreaticoduodenectomy. Materials and methods. During the period 2019–2023, 48 pancreaticoduodenectomies were performed. At the stage of reconstruction, pancreatogastrostomy was used for the first time as an alternative to pancreatic jejunostomy. This type of reconstruction has a number of technical and anatomical advantages. Results. The incidence of postoperative bleeding was 12.5% (n=6). In all observations, intraluminal bleeding from the pancreatic stump into the gastric lumen was noted, which was not associated with the development of a pancreatic fistula. The use of argon plasma coagulation provided a one–stage bleeding control without the need for relaparotomy. Conclusions. Our clinical experience has shown encouraging immediate results. Argon plasma coagulation can be successfully used for bleeding from the pancreatic stump into the gastric lumen without the risk of anastomotic failure.
- Open Access
- 1 January 2024
- Published by Publishing House Helvetica (Publications) in Науковий вісник Ужгородського університету. Серія Медицина
- No. 1(69),p. 36-40
ENDOSCOPIC STUDY OF THE FUNCTION OF THE JUNCTION AND THE TIMING OF EPITHELIALIZATION OF THE PANCREATOGASTRIC ANASTOMOSIS AFTER PANCREATODUODENECTOMY
Introduction: the failure of pancreatodigestive anastomosis, as the most common complication after pancreatectomy, can be associated with the complexity of the healing processes of tissues of different embryogenesis, especially when forming an anastomosis between the wall of the gastrointestinal tract and a parenchymal organ, such as the pancreas, which has no serous and mucous membranes, except for the pancreatic duct. So far, the healing processes of pancreatodigestive anastomoses have not been studied. Endoscope access to the pancreatogastrojejunal anastomosis allows visualizing the processes of epithelialization of the pancreatic stump invaded into the gastric lumen. The purpose of the study: to conduct an endoscopic study of the healing processes of the pancreatogastroanastomosis and to determine the timing of pancreatic stump epithelialization. Materials and methods. Pancreatogastroanastomosis at the reconstructive stage of pancreatectomy was used in 35 cases. The pancreatic stump was drained by the lost drainage of the ductus arteriosus and invaded the gastric lumen through the posterior wall. This technique of pancreatoduodenectomy allows for endoscopic examination of the pancreatogastrostomy both in the early and late postoperative period. Endoscopic examination of the pancreatogastrojejunostomy in the postoperative period was performed in 17 patients, with an interval of 1 month to 1 year. Attention was paid to the function of the connection and the timing of anastomotic epithelialization. Patients with pancreatic fistula type B and C were not studied. Results and discussion. By the end of the first month, the pancreatic stump was covered with fibrin, and single, small granulations with areas of epithelialization were seen along its periphery. In the next 3–4 months, there was a circular layering of fresh gastric mucosa, from the periphery to the center of the pancreatic stump. The fresh mucosa filled all the defects and recesses of the anastomosis area. The oculus of the bile duct was visualized as a rounded shape, up to 2 mm in diameter. By the 6th month, the epithelialization of the anastomosis zone was completed. In the following months, the mucous membrane in the anastomosis area was atrophic, with no signs of inflammation. Conclusions: 1. Epithelialization of the pancreatogastroanastomosis occurs due to the layering of fresh gastric mucosa on the invaded pancreatic stump from the periphery to the center. 2. Epithelialization of the invagination begins by the end of the first, beginning of the second month, from 2 to 4 months – intensive layering of the gastric mucosa on the pancreatic stump occurs. After 5 months, the gastric mucosa completely immerses the invaded pancreatic stump, with the surface of the anastomosis area leveled. 3. The healing of the pancreatogastroanastomosis ends at 6 months after surgery. The ductus arteriosus becomes rounded with a diameter of up to 2 mm. In the long-term period, the anastomosis zone is represented by an atrophic mucous membrane with no inflammation and the same color as the surrounding gastric mucosa. 4. Smooth healing of the pancreatogastroanastomosis makes it possible to recommend its use at the reconstructive stage in pancreatoduodenectomy. Вступ. Неспроможність панкреатодигестивного анастомозу, як найчастіше ускладнення після панкреатдуоденектомії, можна пов’язати зі складністю процесів загоєння різних за ембріогенезом тканин, особливо при формуванні анастомозу між стінкою шлунково-кишкового тракту та паренхіматозним органом, таким як підшлункова залоза, який не має серозних та слизових оболонок, за винятком панкреатичної протоки. До цього часу процеси загоєння панкреатодигестивниханастомозів не вивчені. Доступ ендоскопа до панкреатогастроанастомозу дозволяє візуалізувати процеси епітелізації кукси підшлункової залози, інвагінованої в просвіт шлунку. Мета дослідження: провести ендоскопічне дослідження процесів загоєння панкреатогастроанастомозу та визначити терміни епітелізації кукси підшлункової залози. Матеріали та методи. Панкреатогастроанастомоз на реконструктивному етапі при панкреатектомії застосовано у 35 випадках. Кукса підшлункової залози дренувалася втраченим дренажем вірсунгової протоки та інвагінувалася у просвіт шлунку через задню стінку. Дана методика панкреатодуоденектомії дозволяє проводити ендоскопічне дослідження панкреатогастростомії як в ранньому так і пізньому післяопераційному періоді. Ендоскопічне дослідження панкреатогастроанастомозу в післяопераційному періоді проведено у 17 пацієнтів інтервалом 1 місяць – 1 рік. Увага приділялася функції сполучення і термінам епітелізації анастомозу. Пацієнтам з панкреатичною норицею тип В і С – дослідження не...
- 1 January 2024
- Published by Publishing House Helvetica (Publications) in Науковий вісник Ужгородського університету. Серія Медицина
- No. 1(69),p. 36-40
Open AccessENDOSCOPIC STUDY OF THE FUNCTION OF THE JUNCTION AND THE TIMING OF EPITHELIALIZATION OF THE PANCREATOGASTRIC ANASTOMOSIS AFTER PANCREATODUODENECTOMY
Introduction: the failure of pancreatodigestive anastomosis, as the most common complication after pancreatectomy, can be associated with the complexity of the healing processes of tissues of different embryogenesis, especially when forming an anastomosis between the wall of the gastrointestinal tract and a parenchymal organ, such as the pancreas, which has no serous and mucous membranes, except for the pancreatic duct. So far, the healing processes of pancreatodigestive anastomoses have not been studied. Endoscope access to the pancreatogastrojejunal anastomosis allows visualizing the processes of epithelialization of the pancreatic stump invaded into the gastric lumen. The purpose of the study: to conduct an endoscopic study of the healing processes of the pancreatogastroanastomosis and to determine the timing of pancreatic stump epithelialization. Materials and methods. Pancreatogastroanastomosis at the reconstructive stage of pancreatectomy was used in 35 cases. The pancreatic stump was drained by the lost drainage of the ductus arteriosus and invaded the gastric lumen through the posterior wall. This technique of pancreatoduodenectomy allows for endoscopic examination of the pancreatogastrostomy both in the early and late postoperative period. Endoscopic examination of the pancreatogastrojejunostomy in the postoperative period was performed in 17 patients, with an interval of 1 month to 1 year. Attention was paid to the function of the connection and the timing of anastomotic epithelialization. Patients with pancreatic fistula type B and C were not studied. Results and discussion. By the end of the first month, the pancreatic stump was covered with fibrin, and single, small granulations with areas of epithelialization were seen along its periphery. In the next 3–4 months, there was a circular layering of fresh gastric mucosa, from the periphery to the center of the pancreatic stump. The fresh mucosa filled all the defects and recesses of the anastomosis area. The oculus of the bile duct was visualized as a rounded shape, up to 2 mm in diameter. By the 6th month, the epithelialization of the anastomosis zone was completed. In the following months, the mucous membrane in the anastomosis area was atrophic, with no signs of inflammation. Conclusions: 1. Epithelialization of the pancreatogastroanastomosis occurs due to the layering of fresh gastric mucosa on the invaded pancreatic stump from the periphery to the center. 2. Epithelialization of the invagination begins by the end of the first, beginning of the second month, from 2 to 4 months – intensive layering of the gastric mucosa on the pancreatic stump occurs. After 5 months, the gastric mucosa completely immerses the invaded pancreatic stump, with the surface of the anastomosis area leveled. 3. The healing of the pancreatogastroanastomosis ends at 6 months after surgery. The ductus arteriosus becomes rounded with a diameter of up to 2 mm. In the long-term period, the anastomosis zone is represented by an atrophic mucous membrane with no inflammation and the same color as the surrounding gastric mucosa. 4. Smooth healing of the pancreatogastroanastomosis makes it possible to recommend its use at the reconstructive stage in pancreatoduodenectomy. Вступ. Неспроможність панкреатодигестивного анастомозу, як найчастіше ускладнення після панкреатдуоденектомії, можна пов’язати зі складністю процесів загоєння різних за ембріогенезом тканин, особливо при формуванні анастомозу між стінкою шлунково-кишкового тракту та паренхіматозним органом, таким як підшлункова залоза, який не має серозних та слизових оболонок, за винятком панкреатичної протоки. До цього часу процеси загоєння панкреатодигестивниханастомозів не вивчені. Доступ ендоскопа до панкреатогастроанастомозу дозволяє візуалізувати процеси епітелізації кукси підшлункової залози, інвагінованої в просвіт шлунку. Мета дослідження: провести ендоскопічне дослідження процесів загоєння панкреатогастроанастомозу та визначити терміни епітелізації кукси підшлункової залози. Матеріали та методи. Панкреатогастроанастомоз на реконструктивному етапі при панкреатектомії застосовано у 35 випадках. Кукса підшлункової залози дренувалася втраченим дренажем вірсунгової протоки та інвагінувалася у просвіт шлунку через задню стінку. Дана методика панкреатодуоденектомії дозволяє проводити ендоскопічне дослідження панкреатогастростомії як в ранньому так і пізньому післяопераційному періоді. Ендоскопічне дослідження панкреатогастроанастомозу в післяопераційному періоді проведено у 17 пацієнтів інтервалом 1 місяць – 1 рік. Увага приділялася функції сполучення і термінам епітелізації анастомозу. Пацієнтам з панкреатичною норицею тип В і С – дослідження не...
- Open Access
- 30 September 2023
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 90 (4) , 2-5
Analysis of early postoperative outcomes after pancreatoduodenectomy with Braun entero-enteroanastomosis
Objective. To evaluate early postoperative results after pancreatoduodenectomy with Brown entero–enteroanastomosis. Materials and methods. Collected data of 162 patients who underwent pancreatoduodenectomy from 2015 to 2023. Group 1 was formed retrospectively and contained patients without Braun entero–enterostomy. Prospectivile formed Group 2 contained patients with Braun entero–enterostomy. The comparative analysis of 2 groups was performed. Results. The overall incidence of delayed gastric emptying in both groups was 9.4%. At the same time, the frequency of delayed gastric emptying in the group 2 was significantly lower – 5.9% versus 15% in group 1, although the difference did not reach statistical significance (p=0.896). Conclusion. Braun entero–enteroanastomosis during pancreatoduodenectomy reduced the frequency of delayed emptying, while not increasing the number of other complications.
- 30 September 2023
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 90 (4) , 2-5
Open AccessAnalysis of early postoperative outcomes after pancreatoduodenectomy with Braun entero-enteroanastomosis
Objective. To evaluate early postoperative results after pancreatoduodenectomy with Brown entero–enteroanastomosis. Materials and methods. Collected data of 162 patients who underwent pancreatoduodenectomy from 2015 to 2023. Group 1 was formed retrospectively and contained patients without Braun entero–enterostomy. Prospectivile formed Group 2 contained patients with Braun entero–enterostomy. The comparative analysis of 2 groups was performed. Results. The overall incidence of delayed gastric emptying in both groups was 9.4%. At the same time, the frequency of delayed gastric emptying in the group 2 was significantly lower – 5.9% versus 15% in group 1, although the difference did not reach statistical significance (p=0.896). Conclusion. Braun entero–enteroanastomosis during pancreatoduodenectomy reduced the frequency of delayed emptying, while not increasing the number of other complications.